BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
0.9101
+0.0426 (4.91%)
At close: Oct 13, 2025, 4:00 PM EDT
0.9001
-0.0100 (-1.10%)
After-hours: Oct 13, 2025, 7:38 PM EDT
BioAtla Market Cap
BioAtla has a market cap or net worth of $53.44 million as of October 13, 2025. Its market cap has decreased by -31.54% in one year.
Market Cap
53.44M
Enterprise Value
41.58M
1-Year Change
-31.54%
Ranking
Category
Stock Price
$0.91
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $577.60M to $53.44M, a decrease of -90.75%. That is a compound annual growth rate of -38.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 50.94M | 48.50% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -69.81% |
| Dec 30, 2022 | 390.66M | -45.97% |
| Dec 31, 2021 | 723.09M | -36.84% |
| Dec 31, 2020 | 1.14B | 98.22% |
| Dec 16, 2020 | 577.60M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |